Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20061538rdf:typepubmed:Citationlld:pubmed
pubmed-article:20061538lifeskim:mentionsumls-concept:C0018787lld:lifeskim
pubmed-article:20061538lifeskim:mentionsumls-concept:C0031621lld:lifeskim
pubmed-article:20061538lifeskim:mentionsumls-concept:C0243026lld:lifeskim
pubmed-article:20061538lifeskim:mentionsumls-concept:C0277785lld:lifeskim
pubmed-article:20061538lifeskim:mentionsumls-concept:C1336634lld:lifeskim
pubmed-article:20061538lifeskim:mentionsumls-concept:C0023688lld:lifeskim
pubmed-article:20061538lifeskim:mentionsumls-concept:C0599946lld:lifeskim
pubmed-article:20061538lifeskim:mentionsumls-concept:C0441712lld:lifeskim
pubmed-article:20061538pubmed:issue3lld:pubmed
pubmed-article:20061538pubmed:dateCreated2010-2-25lld:pubmed
pubmed-article:20061538pubmed:abstractTextMyocardial dysfunction is a major consequence of septic shock and contributes to the high mortality of sepsis. In the present study, we examined the effect of Toll-like receptor 2 (TLR2) ligands, peptidoglycan (PGN), and Pam3CSK4 (Pam3) on cardiac function in cecal ligation and puncture (CLP)-induced sepsis in mice. We also investigated whether the phosphoinositide 3-kinase (PI3K)/Akt signaling pathway is involved in the effect of TLR2 ligands on cardiac function in CLP mice. PGN was administered to C57B6/L mice 1 h before the induction of CLP. Sham surgically operated mice served as a control. Cardiac function indexes (rate of change in left ventricular pressure, stroke work, cardiac output, and ejection fraction) were examined by a microconductance pressure catheter. Cardiac function was significantly decreased 6 h after CLP-induced sepsis compared with sham-operated control. In contrast, PGN administration attenuated CLP-induced cardiac dysfunction. Importantly, the therapeutic treatment with Pam3 1 h after CLP also significantly attenuated cardiac dysfunction in CLP mice. However, the beneficial effect of TLR2 ligands on cardiac dysfunction in CLP-mice was abolished in TLR2-deficient mice. PGN administration significantly increased the levels of phospho-Akt and phospho-GSK-3beta in the myocardium compared with the levels in untreated CLP mice. PI3K inhibition abolished the PGN-induced attenuation of cardiac dysfunction in CLP mice. In conclusion, these data demonstrate that the administration of TLR2 ligands, PGN, or Pam3 attenuates cardiac dysfunction in septic mice via a TLR2/PI3K-dependent mechanism. More significantly, Pam3 therapeutic treatment will have a potential clinical relevance.lld:pubmed
pubmed-article:20061538pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:languageenglld:pubmed
pubmed-article:20061538pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:citationSubsetIMlld:pubmed
pubmed-article:20061538pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061538pubmed:statusMEDLINElld:pubmed
pubmed-article:20061538pubmed:monthMarlld:pubmed
pubmed-article:20061538pubmed:issn1522-1539lld:pubmed
pubmed-article:20061538pubmed:authorpubmed-author:JosKKlld:pubmed
pubmed-article:20061538pubmed:authorpubmed-author:ChenLuLlld:pubmed
pubmed-article:20061538pubmed:authorpubmed-author:WilliamsDavid...lld:pubmed
pubmed-article:20061538pubmed:authorpubmed-author:SinghKrishnaKlld:pubmed
pubmed-article:20061538pubmed:authorpubmed-author:GaoXiangXlld:pubmed
pubmed-article:20061538pubmed:authorpubmed-author:KelleyJimJlld:pubmed
pubmed-article:20061538pubmed:authorpubmed-author:LiChuanfuClld:pubmed
pubmed-article:20061538pubmed:authorpubmed-author:KalbfleischJo...lld:pubmed
pubmed-article:20061538pubmed:authorpubmed-author:HuaFangFlld:pubmed
pubmed-article:20061538pubmed:authorpubmed-author:HaTuanzhuTlld:pubmed
pubmed-article:20061538pubmed:authorpubmed-author:KaoRace LRLlld:pubmed
pubmed-article:20061538pubmed:authorpubmed-author:HuYulongYlld:pubmed
pubmed-article:20061538pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20061538pubmed:volume298lld:pubmed
pubmed-article:20061538pubmed:ownerNLMlld:pubmed
pubmed-article:20061538pubmed:authorsCompleteYlld:pubmed
pubmed-article:20061538pubmed:paginationH984-91lld:pubmed
pubmed-article:20061538pubmed:dateRevised2011-11-2lld:pubmed
pubmed-article:20061538pubmed:meshHeadingpubmed-meshheading:20061538...lld:pubmed
pubmed-article:20061538pubmed:meshHeadingpubmed-meshheading:20061538...lld:pubmed
pubmed-article:20061538pubmed:meshHeadingpubmed-meshheading:20061538...lld:pubmed
pubmed-article:20061538pubmed:meshHeadingpubmed-meshheading:20061538...lld:pubmed
pubmed-article:20061538pubmed:meshHeadingpubmed-meshheading:20061538...lld:pubmed
pubmed-article:20061538pubmed:meshHeadingpubmed-meshheading:20061538...lld:pubmed
pubmed-article:20061538pubmed:meshHeadingpubmed-meshheading:20061538...lld:pubmed
pubmed-article:20061538pubmed:meshHeadingpubmed-meshheading:20061538...lld:pubmed
pubmed-article:20061538pubmed:meshHeadingpubmed-meshheading:20061538...lld:pubmed
pubmed-article:20061538pubmed:meshHeadingpubmed-meshheading:20061538...lld:pubmed
pubmed-article:20061538pubmed:meshHeadingpubmed-meshheading:20061538...lld:pubmed
pubmed-article:20061538pubmed:meshHeadingpubmed-meshheading:20061538...lld:pubmed
More...